FDA advisers endorse emergency use of Moderna, Pfizer Covid-19 vaccine in babies, toddlers

Australia News News

FDA advisers endorse emergency use of Moderna, Pfizer Covid-19 vaccine in babies, toddlers
Australia Latest News,Australia Headlines
  • 📰 politico
  • ⏱ Reading Time:
  • 88 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 59%

FDA advisers voted unanimously to endorse Moderna's Covid-19 vaccines for babies and toddlers. The FDA is expected to quickly authorize the vaccine for emergency use. A vote on Pfizer's vaccine is coming soon.

The FDA’s independent vaccine advisers voted unanimously Wednesday to recommend the agency authorize two Covid-19 vaccines for babies, toddlers and preschool-age children, putting the country’s youngest age group one step closer to immunizations nearly two-and-a-half years into the pandemic.

The CDC’s panel of expert advisers will consider whether to recommend the shots’ administration during meetings on Friday and Saturday. Once CDC Director Rochelle Walensky signs off on a recommendation, children are expected to begin receiving shots by Tuesday. Children under 6 who receive the Moderna vaccine will get two 25-microgram doses, four weeks apart. The Pfizer vaccine is two 3-microgram doses three weeks apart, followed by a third dose eight weeks later.

Still, the Biden administration is girding for a slog in convincing parents to quickly vaccinate their young children. Summer vacations — and young children receiving various levels of schooling before age 5 — along with misinformation about vaccines could depress early turnout. Many young children also contracted Covid during the Omicron surge, which could convince parents to hold off on immunizing them until they’re further removed from their natural infections.

Real-world efficacy against the Omicron variant in the 6-month-to-5-year-old age group for Moderna’s vaccine ranged from 36 percent to 51 percent, but efficacy estimates were “generally consistent” with rates seen in observational studies of adults during the same variant waves, the FDA said. “My level of confidence in that number ... I do not have any idea what that number will end up being,” she said of the 80 percent figure for Pfizer’s vaccine, adding that she does think it is effective.

The manufacturers did not report any events in their trials that met the CDC definition for probable or confirmed myocarditis or pericarditis — two types of heart inflammation that have been detected as potential side effects of the messenger RNA vaccines, particularly for males ages 12 to 39.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

politico /  🏆 381. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Advisers Review Moderna, Pfizer COVID-19 Shots for Kids as Young as 6 monthsFDA Advisers Review Moderna, Pfizer COVID-19 Shots for Kids as Young as 6 monthsU.S. government advisers met Wednesday to decide whether to endorse COVID-19 shots for babies, toddlers and preschoolers, moving the nation closer to vaccinations for all ages.
Read more »

FDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young ChildrenFDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young ChildrenThe advisory panel’s meeting moves the Pfizer and Moderna shots one step closer to authorization for one of the last groups of people in the U.S. who haven’t been able to get vaccinated against the coronavirus.
Read more »

FDA panel says Pfizer, Moderna's COVID-19 shots for tots safe and effectiveFDA panel says Pfizer, Moderna's COVID-19 shots for tots safe and effectiveUPDATE: FDA panel says Pfizer, Moderna's COVID-19 shots for kids under 5 are safe and effective
Read more »

FDA advisers to weigh expanding Covid-19 vaccines to younger childrenFDA advisers to weigh expanding Covid-19 vaccines to younger childrenSeveral months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5.
Read more »

FDA Advisers Considering Moderna’s Covid-19 Vaccine for Ages 6 to 17FDA Advisers Considering Moderna’s Covid-19 Vaccine for Ages 6 to 17An advisory committee is set to vote Tuesday on whether to recommend that the Food and Drug Administration authorize use of the Moderna vaccine for 6- to 17-year-olds.
Read more »

FDA advisers consider Moderna’s COVID shots for teens, younger kidsFDA advisers consider Moderna’s COVID shots for teens, younger kidsFDA scientists said there were no confirmed cases of the heart inflammation in Moderna’s kid studies.
Read more »



Render Time: 2025-02-27 22:55:51